Postmarket PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
Device Postmarket Studies PowerPoint PPT Presentation
Device Postmarket Studies - Device Postmarket Studies. Danica Marinac-Dabic, MD, PhD. Chief, Epidemiology Branch ... Longer-term performance including effects of re-treatments & product changes ...
Device Postmarket Studies. Danica Marinac-Dabic, MD, PhD. Chief, Epidemiology Branch ... Longer-term performance including effects of re-treatments & product changes ...
| PowerPoint PPT presentation | free to view
Postmarket Surveillance of Medical Device Adverse Events PowerPoint PPT Presentation
Postmarket Surveillance of Medical Device Adverse Events - Postmarket Surveillance of Medical Device Adverse Events Hesha Jani Duggirala, PhD Epidemiology Branch Division of Postmarket Surveillance Office of Surveillance and ...
Postmarket Surveillance of Medical Device Adverse Events Hesha Jani Duggirala, PhD Epidemiology Branch Division of Postmarket Surveillance Office of Surveillance and ...
| PowerPoint PPT presentation | free to view
Postmarket Surveillance of Medical Device Adverse Events PowerPoint PPT Presentation
Postmarket Surveillance of Medical Device Adverse Events - Division of Postmarket Surveillance. Office of Surveillance ... Center for Devices and Radiological Health ... Device death, serious injuries, and malfunctions ...
Division of Postmarket Surveillance. Office of Surveillance ... Center for Devices and Radiological Health ... Device death, serious injuries, and malfunctions ...
| PowerPoint PPT presentation | free to view
Trends in Postmarket Surveillance PowerPoint PPT Presentation
Trends in Postmarket Surveillance - the effect of user fees on FDA's ability to conduct postmarket surveillance ... Dodd has record on pediatric FDA issues ... MDUFMA | Other Policies ...
the effect of user fees on FDA's ability to conduct postmarket surveillance ... Dodd has record on pediatric FDA issues ... MDUFMA | Other Policies ...
| PowerPoint PPT presentation | free to view
Postmarket Transformation at CDRH: The Role of Statistician PowerPoint PPT Presentation
Postmarket Transformation at CDRH: The Role of Statistician - Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch ... CDRH postmarket responsibilities and challenges. Established roles of the CDRH statisticians ...
Danica Marinac Dabic, M.D., Ph.D. Chief, Epidemiology Branch ... CDRH postmarket responsibilities and challenges. Established roles of the CDRH statisticians ...
| PowerPoint PPT presentation | free to view
Medical Device Registries: Multiple Applications PowerPoint PPT Presentation
Medical Device Registries: Multiple Applications - Medical Device Registries: Multiple Applications Thomas P. Gross, MD, MPH Director Division of Postmarket Surveillance Office of Surveillance & Biometrics
Medical Device Registries: Multiple Applications Thomas P. Gross, MD, MPH Director Division of Postmarket Surveillance Office of Surveillance & Biometrics
| PowerPoint PPT presentation | free to download
Global%20Harmonization%20of%20Medical%20Device%20Regulation:%20Accomplishments,%20Challenges%20and%20Opportunities PowerPoint PPT Presentation
Global%20Harmonization%20of%20Medical%20Device%20Regulation:%20Accomplishments,%20Challenges%20and%20Opportunities - Essential principles conformance vs. review. Postmarket surveillance ... Public declaration vs. de facto practice. Industry must get engaged ...
Essential principles conformance vs. review. Postmarket surveillance ... Public declaration vs. de facto practice. Industry must get engaged ...
| PowerPoint PPT presentation | free to download
Panel questions PowerPoint PPT Presentation
Panel questions - Panel questions Reproduction and teratogenicity Tumorogenicity Radiographic effectiveness Instructions for use Postmarket studies Reproduction and teratogenicity ...
Panel questions Reproduction and teratogenicity Tumorogenicity Radiographic effectiveness Instructions for use Postmarket studies Reproduction and teratogenicity ...
| PowerPoint PPT presentation | free to view
Statement before the Food and Drug Administration Public Hearing on Prescription Drug User Fee Act P PowerPoint PPT Presentation
Statement before the Food and Drug Administration Public Hearing on Prescription Drug User Fee Act P - Made a significant contribution in securing financial resources ... Polypharmacy. Off label uses. Shared Responsibility for Postmarket Surveillance. Manufacturers ...
Made a significant contribution in securing financial resources ... Polypharmacy. Off label uses. Shared Responsibility for Postmarket Surveillance. Manufacturers ...
| PowerPoint PPT presentation | free to view
Summary Recommendations to FDA PowerPoint PPT Presentation
Summary Recommendations to FDA - Summary Recommendations to FDA. Society of Thoracic Surgeons' Perspective ... FDA, as part of their Postmarket Transformation, should develop data ...
Summary Recommendations to FDA. Society of Thoracic Surgeons' Perspective ... FDA, as part of their Postmarket Transformation, should develop data ...
| PowerPoint PPT presentation | free to view
Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 PowerPoint PPT Presentation
Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 - Dun and Bradstreet FY 04 data shows the device industry grew from 13,579 to 14, ... and partnerships for evaluating new technology based on sound science in a ...
Dun and Bradstreet FY 04 data shows the device industry grew from 13,579 to 14, ... and partnerships for evaluating new technology based on sound science in a ...
| PowerPoint PPT presentation | free to view
CDRH Update Facilitating Medical Device Innovation and Technology PowerPoint PPT Presentation
CDRH Update Facilitating Medical Device Innovation and Technology - Medical Device User Fee and Modernization Act of 2002 (MDUFMA)
Medical Device User Fee and Modernization Act of 2002 (MDUFMA)
| PowerPoint PPT presentation | free to view
Unique Device Identification (UDI): Implementation and Adoption PowerPoint PPT Presentation
Unique Device Identification (UDI): Implementation and Adoption - Unique Device Identification (UDI): Implementation and Adoption Leslie M Tompkins, PhD FDA, Center for Devices and Radiological Health UDI Lead, Standards and ...
Unique Device Identification (UDI): Implementation and Adoption Leslie M Tompkins, PhD FDA, Center for Devices and Radiological Health UDI Lead, Standards and ...
| PowerPoint PPT presentation | free to download
CDRH: Minimizing Risk of TSE Agents in Medical Devices PowerPoint PPT Presentation
CDRH: Minimizing Risk of TSE Agents in Medical Devices - Neurological Devices/General Surgical Instruments. In Vitro Diagnostic Devices. 4 ... General Surgical instruments (scalpels, scissors, biopsy forceps, retractors) 8 ...
Neurological Devices/General Surgical Instruments. In Vitro Diagnostic Devices. 4 ... General Surgical instruments (scalpels, scissors, biopsy forceps, retractors) 8 ...
| PowerPoint PPT presentation | free to view
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance PowerPoint PPT Presentation
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance - Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance
Parallel Session 1 Post Market Adverse Events: FDA Reporting Systems and Surveillance
| PowerPoint PPT presentation | free to view
Drug Quality and Safety: Comparison of EMEA and FDA Rules PowerPoint PPT Presentation
Drug Quality and Safety: Comparison of EMEA and FDA Rules - ... most products on the EU market were approved by Member State agencies. ... GMPs apply to Active Pharmaceutical Ingredients After Eprex and Chiron, ...
... most products on the EU market were approved by Member State agencies. ... GMPs apply to Active Pharmaceutical Ingredients After Eprex and Chiron, ...
| PowerPoint PPT presentation | free to download
Combination Products CBER Report PowerPoint PPT Presentation
Combination Products CBER Report - The Office will handle disputes involving timeliness, unless 'clearly premarket' 7 ... What is the true extent of this authority? 10. Office's Report to ...
The Office will handle disputes involving timeliness, unless 'clearly premarket' 7 ... What is the true extent of this authority? 10. Office's Report to ...
| PowerPoint PPT presentation | free to view
How does the U.S. FDA Regulate Medical Devices? PowerPoint PPT Presentation
How does the U.S. FDA Regulate Medical Devices? - ... 34.00 6987.00 13.00 7225.00 4789.00 1284.00 556.00 6629.00 344.00 64.00 7037.00 188.00 46736.00 9077.00 8209.00 7242.00 24528.00 11284.00 4682.00 40494.00 6242 ...
... 34.00 6987.00 13.00 7225.00 4789.00 1284.00 556.00 6629.00 344.00 64.00 7037.00 188.00 46736.00 9077.00 8209.00 7242.00 24528.00 11284.00 4682.00 40494.00 6242 ...
| PowerPoint PPT presentation | free to view
Risk%20Management,%20Risk%20Communication,%20and%20Drug%20Safety:%20The%20U.S.%20Experience PowerPoint PPT Presentation
Risk%20Management,%20Risk%20Communication,%20and%20Drug%20Safety:%20The%20U.S.%20Experience - FDA lacks authority and funding for adequate oversight of drug safety ... FDA imprimatur on unvalidated safety information. Potential for confusion, overreaction ...
FDA lacks authority and funding for adequate oversight of drug safety ... FDA imprimatur on unvalidated safety information. Potential for confusion, overreaction ...
| PowerPoint PPT presentation | free to download
Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 PowerPoint PPT Presentation
Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 - Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 Dan Schultz Director, CDRH
Critical Path Research: Getting New Technology from Bench to Bedside A Device Perspective FDA Science Board November 5, 2004 Dan Schultz Director, CDRH
| PowerPoint PPT presentation | free to view
Other Issues for Statisticians in Medical Devices PowerPoint PPT Presentation
Other Issues for Statisticians in Medical Devices - Devices that diagnose and then deliver therapy. Separate drug, separate ... 9 device sessions in Minneapolis orchestrated by a committee from industry and ...
Devices that diagnose and then deliver therapy. Separate drug, separate ... 9 device sessions in Minneapolis orchestrated by a committee from industry and ...
| PowerPoint PPT presentation | free to view
Parallel Session 1 The Role of the Statistician in Post-Marketing, Including Surveillance PowerPoint PPT Presentation
Parallel Session 1 The Role of the Statistician in Post-Marketing, Including Surveillance - Provide insight into the role of the statistician in FDA post-marketing ... 8:20: Danica Marinac-Dabic, MD, PhD (Chief, Epidemiology Branch, OSB, CDRH) ...
Provide insight into the role of the statistician in FDA post-marketing ... 8:20: Danica Marinac-Dabic, MD, PhD (Chief, Epidemiology Branch, OSB, CDRH) ...
| PowerPoint PPT presentation | free to view
P000058 Medtronic Sofamor Danek InFUSE? Bone Graft/LT-Cage Lumbar Tapered Fusion Device PowerPoint PPT Presentation
P000058 Medtronic Sofamor Danek InFUSE? Bone Graft/LT-Cage Lumbar Tapered Fusion Device - P000058 Medtronic Sofamor Danek InFUSE Bone Graft/LT-Cage Lumbar Tapered Fusion Device Restorative Devices Branch Division of General, Restorative and Neurological ...
P000058 Medtronic Sofamor Danek InFUSE Bone Graft/LT-Cage Lumbar Tapered Fusion Device Restorative Devices Branch Division of General, Restorative and Neurological ...
| PowerPoint PPT presentation | free to view
FDA Update PowerPoint PPT Presentation
FDA Update - Chinese authorities will require registration of facilities in phased approach ... Title V Best Pharmaceuticals for Children Act. Title VI Reagan-Udall Foundation ...
Chinese authorities will require registration of facilities in phased approach ... Title V Best Pharmaceuticals for Children Act. Title VI Reagan-Udall Foundation ...
| PowerPoint PPT presentation | free to view
Facilitating Medical Innovation and Technology: The Role of FDA PowerPoint PPT Presentation
Facilitating Medical Innovation and Technology: The Role of FDA - Title: Facilitating Medical Innovation and Technology: The Role of FDA Author: CDRH Last modified by: finsem1 Created Date: 2/7/2005 7:05:57 PM Document presentation ...
Title: Facilitating Medical Innovation and Technology: The Role of FDA Author: CDRH Last modified by: finsem1 Created Date: 2/7/2005 7:05:57 PM Document presentation ...
| PowerPoint PPT presentation | free to view
Facilitating Medical Innovation and Technology: The Role of FDA PowerPoint PPT Presentation
Facilitating Medical Innovation and Technology: The Role of FDA - In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any ...
In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records fit for any ...
| PowerPoint PPT presentation | free to view
Cardiovascular and Renal Drugs Advisory Committee PowerPoint PPT Presentation
Cardiovascular and Renal Drugs Advisory Committee - vascularity in organs. myocardial perfusion. other? 5. Marketed Ultrasound Contrast Agents ... PMC to perform a surveillance study of Definity 'as it is used in ...
vascularity in organs. myocardial perfusion. other? 5. Marketed Ultrasound Contrast Agents ... PMC to perform a surveillance study of Definity 'as it is used in ...
| PowerPoint PPT presentation | free to view
Diapositiva 1 PowerPoint PPT Presentation
Diapositiva 1 - Espa a (AGEMED) y Europa (EMEA) Mariano Madurga. Divisi n de Farmacoepidemiologia y Farmacovigilancia Agencia Espa ola del Medicamento.
Espa a (AGEMED) y Europa (EMEA) Mariano Madurga. Divisi n de Farmacoepidemiologia y Farmacovigilancia Agencia Espa ola del Medicamento.
| PowerPoint PPT presentation | free to download
AIDS TREATMENT ACTIVIST COALITION ATAC DRUG DEVELOPMENT COMMITTEE DDC PowerPoint PPT Presentation
AIDS TREATMENT ACTIVIST COALITION ATAC DRUG DEVELOPMENT COMMITTEE DDC - Congress reauthorized the Prescription Drug User Fee Act (PADUFA) for another ... appropriate, the Secretary shall promulgate regulations requiring such a statement. ...
Congress reauthorized the Prescription Drug User Fee Act (PADUFA) for another ... appropriate, the Secretary shall promulgate regulations requiring such a statement. ...
| PowerPoint PPT presentation | free to download
Incident Reports and field Safety Corrective Action ( FSCA) PowerPoint PPT Presentation
Incident Reports and field Safety Corrective Action ( FSCA) - W hen Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Maintain traceability system for surveillance purposes.
W hen Medical devices subjected to Field safety notice distributed in KSA market, the establishment shall: Maintain traceability system for surveillance purposes.
| PowerPoint PPT presentation | free to view
FDA Amendments Act FDAAA: New Regulatory Authorities PowerPoint PPT Presentation
FDA Amendments Act FDAAA: New Regulatory Authorities - active post market risk identification and analysis system (to be established ... May not introduce drug into interstate commerce if in violation of provision ...
active post market risk identification and analysis system (to be established ... May not introduce drug into interstate commerce if in violation of provision ...
| PowerPoint PPT presentation | free to view
Neurologic Adverse Events Associated with Absorbable Hemostatic Agents PowerPoint PPT Presentation
Neurologic Adverse Events Associated with Absorbable Hemostatic Agents - Center for Devices and Radiological Health. Office of Surveillance and Biometrics ... Patient was taken to surgery for a T5-T8 laminectomy where a mass of hemostatic ...
Center for Devices and Radiological Health. Office of Surveillance and Biometrics ... Patient was taken to surgery for a T5-T8 laminectomy where a mass of hemostatic ...
| PowerPoint PPT presentation | free to view
FDA Perspective on IVD Regulation PowerPoint PPT Presentation
FDA Perspective on IVD Regulation - Advisory panel meeting on Fujirebio Diagnostics Inc. ... Quest Subsidiary, Nichols Institute Diagnostics, pleaded guilty to felony ...
Advisory panel meeting on Fujirebio Diagnostics Inc. ... Quest Subsidiary, Nichols Institute Diagnostics, pleaded guilty to felony ...
| PowerPoint PPT presentation | free to view
NCMD Medical Device Forum May 16, 2005 PowerPoint PPT Presentation
NCMD Medical Device Forum May 16, 2005 - Testing and approval or rejection of components, drug product containers, and closures ... 40. Combination Product: Marketing Applications. Number and type of ...
Testing and approval or rejection of components, drug product containers, and closures ... 40. Combination Product: Marketing Applications. Number and type of ...
| PowerPoint PPT presentation | free to view
REGULATION OF COMBINATION PRODUCTS PowerPoint PPT Presentation
REGULATION OF COMBINATION PRODUCTS - Examples are (1) monoclonal antibody combined with a therapeutic drug; (2) drug ... and (4) surgical tray with surgical instruments, drapes and antimicrobial swabs ...
Examples are (1) monoclonal antibody combined with a therapeutic drug; (2) drug ... and (4) surgical tray with surgical instruments, drapes and antimicrobial swabs ...
| PowerPoint PPT presentation | free to view
Pharmacovigilance in the Post-Marketing Setting: Results from the RADAR Project PowerPoint PPT Presentation
Pharmacovigilance in the Post-Marketing Setting: Results from the RADAR Project - Undetected toxicities at time of FDA approval ... Basic science correlative (%) Laboratory/ Radiology (%) History/Physical examination ...
Undetected toxicities at time of FDA approval ... Basic science correlative (%) Laboratory/ Radiology (%) History/Physical examination ...
| PowerPoint PPT presentation | free to download
Steve Ubl PowerPoint PPT Presentation
Steve Ubl - The Public Policy Environment. Large deficits. Rising health care costs ... U.S. Device Industry Now Receives more than 50% of Revenues from Foreign Sales ...
The Public Policy Environment. Large deficits. Rising health care costs ... U.S. Device Industry Now Receives more than 50% of Revenues from Foreign Sales ...
| PowerPoint PPT presentation | free to download
Unique Device Identification (UDI) PowerPoint PPT Presentation
Unique Device Identification (UDI) - Title: Identifying Real-world Human Factors Issues Author: Jay Crowley Last modified by: Reed, Terrie Created Date: 6/17/1995 11:31:02 PM Document presentation format
Title: Identifying Real-world Human Factors Issues Author: Jay Crowley Last modified by: Reed, Terrie Created Date: 6/17/1995 11:31:02 PM Document presentation format
| PowerPoint PPT presentation | free to view
Risk Communication Advisory Committee Risk Communication Issues in the Food and Drug Administration PowerPoint PPT Presentation
Risk Communication Advisory Committee Risk Communication Issues in the Food and Drug Administration - ... Services shall submit the report under this paragraph to the Committee on Health, ... and Pensions of the Senate and the Committee on Energy and Commerce ...
... Services shall submit the report under this paragraph to the Committee on Health, ... and Pensions of the Senate and the Committee on Energy and Commerce ...
| PowerPoint PPT presentation | free to view
FDA Sentinel Initiative PowerPoint PPT Presentation
FDA Sentinel Initiative - Title Reporting Information Regarding Falsification of Data Proposed Rule Author: pbeersblock Last modified by: vivien Created Date: 10/13/2006 10:46:29 AM
Title Reporting Information Regarding Falsification of Data Proposed Rule Author: pbeersblock Last modified by: vivien Created Date: 10/13/2006 10:46:29 AM
| PowerPoint PPT presentation | free to download
The U.S. Approach to Risk Management PowerPoint PPT Presentation
The U.S. Approach to Risk Management - The most significant amendments to the Federal Food, Drug, and Cosmetic Act ... (NDAs), Biologic License Applications (BLAs), Abbreviated New Drug Applications ...
The most significant amendments to the Federal Food, Drug, and Cosmetic Act ... (NDAs), Biologic License Applications (BLAs), Abbreviated New Drug Applications ...
| PowerPoint PPT presentation | free to download
Center for Devices and Radiological Health MassMedic May 2006 PowerPoint PPT Presentation
Center for Devices and Radiological Health MassMedic May 2006 - Director, Office of Science and Engineering Laboratories, CDRH ... Colonic polyp CAD. Computer phantom of cardiovascular disease. High-performance computing ...
Director, Office of Science and Engineering Laboratories, CDRH ... Colonic polyp CAD. Computer phantom of cardiovascular disease. High-performance computing ...
| PowerPoint PPT presentation | free to view
Pharmacovigilance and Drug Safety Compliance Update PowerPoint PPT Presentation
Pharmacovigilance and Drug Safety Compliance Update - Pharmacovigilance and Drug Safety Compliance Update GAP Analysis: How We Get to Where We Want to Be John P. Ford Sidley Austin LLP Core PV Concepts Risk ...
Pharmacovigilance and Drug Safety Compliance Update GAP Analysis: How We Get to Where We Want to Be John P. Ford Sidley Austin LLP Core PV Concepts Risk ...
| PowerPoint PPT presentation | free to download
Assessing%20the%20Safety%20of%20Marketed%20Drugs%20Current%20Issues%20and%20Controversies PowerPoint PPT Presentation
Assessing%20the%20Safety%20of%20Marketed%20Drugs%20Current%20Issues%20and%20Controversies - Assessing the Safety of Marketed Drugs. Current Issues and Controversies ... Drug therapy for individuals still largely empiric. 17 ...
Assessing the Safety of Marketed Drugs. Current Issues and Controversies ... Drug therapy for individuals still largely empiric. 17 ...
| PowerPoint PPT presentation | free to download
FDA and Federal Law: Background and Implementation PowerPoint PPT Presentation
FDA and Federal Law: Background and Implementation - Statutes are the US governments' legal authority. ... US Customs / Money (Treasury) Law Enforcement (Dept. of Justice) Crops and animals (Dept. of Agriculture) ...
Statutes are the US governments' legal authority. ... US Customs / Money (Treasury) Law Enforcement (Dept. of Justice) Crops and animals (Dept. of Agriculture) ...
| PowerPoint PPT presentation | free to view
Good Laboratory Management: PowerPoint PPT Presentation
Good Laboratory Management: - Good Laboratory Management: Means compliance with the correct regulations for each individual study ..
Good Laboratory Management: Means compliance with the correct regulations for each individual study ..
| PowerPoint PPT presentation | free to download
Regulating Wireless Devices PowerPoint PPT Presentation
Regulating Wireless Devices - Surgical instruments, wound dressings, toothbrush. General Controls ... Good Manufacturing Practice (Quality System Regulation) Device labeling ...
Surgical instruments, wound dressings, toothbrush. General Controls ... Good Manufacturing Practice (Quality System Regulation) Device labeling ...
| PowerPoint PPT presentation | free to view
The Role of Medicare National Coverage in the Regulatory Process PowerPoint PPT Presentation
The Role of Medicare National Coverage in the Regulatory Process - Evidence-based medicine de-emphasizes intuition, unsystematic clinical ... PET scans for oncology indications. Home Oxygen. 18 ' ...
Evidence-based medicine de-emphasizes intuition, unsystematic clinical ... PET scans for oncology indications. Home Oxygen. 18 ' ...
| PowerPoint PPT presentation | free to download
Unique Device Identification PowerPoint PPT Presentation
Unique Device Identification - Manufacturers' own number/catalogue number ... Cardinal Health. BD. Business Name. 888021932. Vendor Catalog Number. 8938M25. Vendor Catalog Number ...
Manufacturers' own number/catalogue number ... Cardinal Health. BD. Business Name. 888021932. Vendor Catalog Number. 8938M25. Vendor Catalog Number ...
| PowerPoint PPT presentation | free to view
Hyperlipidemia PowerPoint PPT Presentation
Hyperlipidemia - Type of treatment depends on the number of risk factors and CAD risk factors ... DR3/DR4/DR5/DR7. DR3- Type I Diabets. DR4- Rheumatoid athritis, Type I Diabetes ...
Type of treatment depends on the number of risk factors and CAD risk factors ... DR3/DR4/DR5/DR7. DR3- Type I Diabets. DR4- Rheumatoid athritis, Type I Diabetes ...
| PowerPoint PPT presentation | free to view
Improving Regulatory Decisions: Janus Clinical Trials Repository The Sentinel Initiative PowerPoint PPT Presentation
Improving Regulatory Decisions: Janus Clinical Trials Repository The Sentinel Initiative - Improving Regulatory Decisions: Janus Clinical Trials Repository The Sentinel Initiative Armando Oliva, M.D. Senior Biomedical Informatics Advisor
Improving Regulatory Decisions: Janus Clinical Trials Repository The Sentinel Initiative Armando Oliva, M.D. Senior Biomedical Informatics Advisor
| PowerPoint PPT presentation | free to view
PostMarketing Safety Information on Medical Products: Potentials for Improvements PowerPoint PPT Presentation
PostMarketing Safety Information on Medical Products: Potentials for Improvements - The views expressed are those of the author, and do not represent an official FDA ... EMRs. Compatability' of data needs with data sources. Richness of detail ...
The views expressed are those of the author, and do not represent an official FDA ... EMRs. Compatability' of data needs with data sources. Richness of detail ...
| PowerPoint PPT presentation | free to view
Bringing Innovative Products to Market Challenges PowerPoint PPT Presentation
Bringing Innovative Products to Market Challenges - Demonstrate safety and probable clinical benefit ... Pre-Clinical Testing. Submit PMA or 510(k) Approval/ Clearance. Post- Market. Pre-IDE ...
Demonstrate safety and probable clinical benefit ... Pre-Clinical Testing. Submit PMA or 510(k) Approval/ Clearance. Post- Market. Pre-IDE ...
| PowerPoint PPT presentation | free to view
Device Classification and Reclassification PowerPoint PPT Presentation
Device Classification and Reclassification - Devices which cannot be classified into Class I because general controls by themselves are insufficient to provide reasonable assurance of the safety and ...
Devices which cannot be classified into Class I because general controls by themselves are insufficient to provide reasonable assurance of the safety and ...
| PowerPoint PPT presentation | free to view
Report from CDRH PowerPoint PPT Presentation
Report from CDRH - CDRH promotes and protects the health of the public by ensuring the safety and ... product-specific websites -- e.g. Cochlear Implants www.fda.gov/cdrh/cochlear ...
CDRH promotes and protects the health of the public by ensuring the safety and ... product-specific websites -- e.g. Cochlear Implants www.fda.gov/cdrh/cochlear ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2025 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
postmarket — Search results on PowerShow.com